Metagenome-assembled genome: MGYG000260502
uncultured bacterium
This sample represents a Third Party Annotation (TPA) Metagenome-assembled genome generated from the metagenomic sample SRS1994025 of study SRP100446.
ENA first public
2026-07-16
INSDC center name
EMG
INSDC status
public
Submitter Id
MGYG000260502
assembly quality
Many fragments with little to no review of assembly other than reporting of standard assembly statistics
assembly software
missing: third party data
binning parameters
missing: third party data
binning software
missing: third party data
broad-scale environmental context
human gut microbiome
broker name
EBI-EMG
collection date
2014-10-17
completeness score
77.59
completeness software
CheckM2_v1.1.0
contamination score
0.37
environmental medium
stool
geographic location (country and/or sea)
missing: third party data
geographic location (latitude)
missing: third party data
geographic location (longitude)
missing: third party data
investigation type
metagenome-assembled genome
isolation_source
human gut metagenome
local environmental context
stool
metagenomic source
human gut metagenome
project name
The presence of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is the most important predictor of liver mortality. The aim of this study was to examine the diagnostic</p><p>accuracy of a gut-microbiota derived metagenomic signature for detecting the presence of advanced fibrosis in NAFLD. In this prospective study, we characterized the microbiome signatures associated with advanced fibrosis (defined as stage 3 or 4 fibrosis) in uniquely well characterized biopsy- and imaging-phenotyped patients with NAFLD. Gut microbiome</p><p>compositions of the patients were determined using whole-genome shotgun sequencing of DNA extracted from stool samples.
sample derived from
SRS1994025
sample name
MGYG000260502
scientific_name
uncultured bacterium
sequencing method
missing: third party data
taxonomic identity marker
multi-marker approach